Thrivent Financial for Lutherans
VIVO

Thrivent Financial for Lutherans’s Meridian Bioscience Inc VIVO Stock Holding History

Thrivent Financial for Lutherans’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-44,874
Closed -$1.49M – 2537
2022
Q4 		$1.49M Sell
44,874
-349
-0.8% -$11.2K ﹤0.01% 1467
2022
Q3 		$1.43M Buy
45,223
+2,412
+6% +$78.1K ﹤0.01% 1446
2022
Q2 		$1.3M Buy
42,811
+7,365
+21% +$199K ﹤0.01% 1534
2022
Q1 		$920K Buy
35,446
+164
+0.5% +$3.9K ﹤0.01% 1880
2021
Q4 		$720K Buy
35,282
+239
+0.7% +$4.58K ﹤0.01% 2037
2021
Q3 		$674K Sell
35,043
-379
-1% -$7.55K ﹤0.01% 2050
2021
Q2 		$786K Sell
35,422
-20
-0.1% -$424 ﹤0.01% 1981
2021
Q1 		$930K Sell
35,442
-213
-0.6% -$5.07K ﹤0.01% 1925
2020
Q4 		$666K Buy
35,655
+114
+0.3% +$2.13K ﹤0.01% 1999
2020
Q3 		$603K Sell
35,541
-281
-0.8% -$5.46K ﹤0.01% 1870
2020
Q2 		$834K Hold
35,822
– – ﹤0.01% 1621
2020
Q1 		$301K Buy
35,822
+1,789
+5% +$15.1K ﹤0.01% 1976
2019
Q4 		$332K Sell
34,033
-92
-0.3% -$864 ﹤0.01% 2042
2019
Q3 		$324K Buy
34,125
+792
+2% +$8.35K ﹤0.01% 2011
2019
Q2 		$396K Buy
33,333
+967
+3% +$11.6K ﹤0.01% 1934
2019
Q1 		$570K Buy
32,366
+2,168
+7% +$36.1K ﹤0.01% 1730
2018
Q4 		$524K Buy
30,198
+664
+2% +$11.3K ﹤0.01% 1531
2018
Q3 		$440K Buy
29,534
+486
+2% +$7.54K ﹤0.01% 1744
2018
Q2 		$462K Buy
29,048
+1,831
+7% +$27.3K ﹤0.01% 1722
2018
Q1 		$386K Buy
27,217
+980
+4% +$14.5K ﹤0.01% 1765
2017
Q4 		$367K Buy
26,237
+517
+2% +$7.57K ﹤0.01% 1827
2017
Q3 		$368K Buy
25,720
+200
+0.8% +$2.86K ﹤0.01% 1708
2017
Q2 		$402K Buy
25,520
+1,880
+8% +$27.1K ﹤0.01% 1632
2017
Q1 		$326K Buy
23,640
+890
+4% +$12.4K ﹤0.01% 1720
2016
Q4 		$403K Buy
22,750
+1,300
+6% +$22.8K ﹤0.01% 1605
2016
Q3 		$414K Buy
21,450
+920
+4% +$18K ﹤0.01% 1552
2016
Q2 		$400K Buy
20,530
+1,260
+7% +$24.7K ﹤0.01% 1526
2016
Q1 		$397K Buy
+19,270
New +$380K ﹤0.01% 1482
2015
Q4 		– Sell
-17,350
Closed -$297K – 2005
2015
Q3 		$297K Buy
17,350
+1,150
+7% +$21K ﹤0.01% 1451
2015
Q2 		$302K Buy
16,200
+700
+5% +$13K ﹤0.01% 1392
2015
Q1 		$296K Buy
15,500
+400
+3% +$7.4K ﹤0.01% 1395
2014
Q4 		$249K Buy
15,100
+50
+0.3% +$858 ﹤0.01% 1488
2014
Q3 		$266K Sell
15,050
-150
-1% -$2.95K ﹤0.01% 1433
2014
Q2 		$314K Buy
15,200
+100
+0.7% +$2.06K ﹤0.01% 1381
2014
Q1 		$329K Hold
15,100
– – ﹤0.01% 1192
2013
Q4 		$401K Hold
15,100
– – ﹤0.01% 1094
2013
Q3 		$357K Sell
15,100
-100
-0.7% -$2.33K ﹤0.01% 1106
2013
Q2 		$327 Buy
+15,200
New +$328K ﹤0.01% 1142

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Thrivent Financial for Lutherans's VIVO Position: Q1 2023 in Review

Thrivent Financial for Lutherans sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 44,874 shares — an estimated $1.49M sold.

Thrivent Financial for Lutherans first reported a position in VIVO in Q2 2013 and held it in 38 quarters. The position peaked at $1.49M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Thrivent Financial for Lutherans reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 44,874 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.49M.
  • Thrivent Financial for Lutherans first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 38 quarters.
  • Thrivent Financial for Lutherans's Meridian Bioscience Inc position peaked at $1.49M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2023, filed 17 May 2023.